Literature DB >> 669704

The HLA system and leprosy in Thailand.

J Greiner, E Schleiermacher, T Smith, V Lenhard, F Vogel.   

Abstract

To investigate immunogenetics of leprosy, 205 leprosy patients (26 with tuberculoid, 57 with borderline-tuberculoid, 21 with borderline, 31 with borderline-lepromatous, and 70 with lepromatous leprosy) have been typed for HLA antigens, and compared with 183 healthy controls from the same region (Northern Thailand). There was no significant difference between the overall group of leprosy patients or the three borderline classes and the controls. The two polar forms, tuberculoid and lepromatous leprosy, however, showed significant associations: HLA-A2 is decreased and HLA-Bw17 is increased in tuberculoid leprosy; HLA-B7 is increased in lepromatous leprosy. When both polar forms are compared with each other, HLA-A2 is significantly higher, HLA-Bw40 lower in patients with lepromatous than in those with tuberculoid leprosy. The results are discussed with respect to the different immune responsiveness in the two polar forms of leprosy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 669704     DOI: 10.1007/BF00283640

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  27 in total

1.  Biochemical, immunological and genetic studies in leprosy. II. Profile of immunoglobulins, complement components and C-reactive protein in sera of leprosy patients and healthy controls.

Authors:  L M Srivastava; D P Agarwal; H W Goedde; R Rohde
Journal:  Tropenmed Parasitol       Date:  1975-06

2.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

3.  Letter: HL-A antigens and hypersensitivity to brain tissue in multiple sclerosis.

Authors:  S Finkelstein; R L Walford; L W Myers; G W Ellison
Journal:  Lancet       Date:  1974-04-20       Impact factor: 79.321

4.  HL-A antigens and susceptibility to diseases. II. Leprosy.

Authors:  E Thorsby; T Godal; B Myrvang
Journal:  Tissue Antigens       Date:  1973

Review 5.  Genetic implications of HLA and disease associations.

Authors:  W B Bias; G A Chase
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

6.  Relations of HL-A and Rh systems to immune reactivity. Joint report of the results of 'HL-A and immune response' workshop, Budapest 1972.

Authors: 
Journal:  Vox Sang       Date:  1974       Impact factor: 2.144

7.  Letter: HL-A antigens in leprosy.

Authors:  A P Reis; F Maia; V F Reis; I M Andrade; A A Campos
Journal:  Lancet       Date:  1974-12-07       Impact factor: 79.321

8.  Association between HLA-B7 and allergic reactions to insulin in insulin-dependent diabetes mellitus.

Authors:  J Bertrams; D Grüneklee
Journal:  Tissue Antigens       Date:  1977-10

9.  Histocompatibility antigens (HL-A) in leprosy.

Authors:  A Dasgupta; N K Mehra; S K Ghei; M C Vaidya
Journal:  Tissue Antigens       Date:  1975-04

10.  Histocompatibility antigens in patients with leprosy.

Authors:  T H Rea; N E Levan; P I Terasaki
Journal:  J Infect Dis       Date:  1976-12       Impact factor: 5.226

View more
  4 in total

Review 1.  HLA and disease.

Authors:  Yogita Ghodke; Kalpana Joshi; Arvind Chopra; Bhushan Patwardhan
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  The genetic hypothesis for susceptibility to lepromatous leprosy.

Authors:  D G Smith
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

Review 3.  Insights into the role of host genetic and T-cell factors in resistance to HIV transmission from studies of highly HIV-exposed Thais.

Authors:  Janet M McNicholl; Nattawan Promadej
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 4.  Role of HLA, KIR, MICA, and cytokines genes in leprosy.

Authors:  Luciana Ribeiro Jarduli; Ana Maria Sell; Pâmela Guimarães Reis; Emília Ângela Sippert; Christiane Maria Ayo; Priscila Saamara Mazini; Hugo Vicentin Alves; Jorge Juarez Vieira Teixeira; Jeane Eliete Laguila Visentainer
Journal:  Biomed Res Int       Date:  2013-07-08       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.